China Resources Medical Holdings Company Limited

Informe acción SEHK:1515

Capitalización de mercado: HK$4.8b

China Resources Medical Holdings Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Hai Yu

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO1.8yrs
Participación del CEOn/a
Permanencia media de la dirección1.8yrs
Promedio de permanencia en la Junta Directiva2.5yrs

Actualizaciones recientes de la dirección

Recent updates

Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down

Nov 14
Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down

Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher

Oct 02
Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher

We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

May 06
We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Apr 26
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Mar 09
Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

Nov 29
Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Oct 19
China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Aug 30
Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

Aug 26
Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Jun 30
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

May 12
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Apr 03
Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Feb 21
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

Jan 10
China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Nov 30
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

Oct 18
Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Sep 21
China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Jul 13
Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Jun 24
Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

Jun 03
China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

Apr 27
China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Apr 22
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Mar 30
Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

Jan 27
Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jan 03
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Nov 19
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Oct 26
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Sep 20
An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

Sep 06
Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Aug 17
China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Jun 21
Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Jun 09
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

May 03
Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

Apr 22
China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt

Mar 27
We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt

CEO

Hai Yu (56 yo)

1.8yrs

Permanencia

Mr. Hai Yu is Chief Executive Officer & Executive Director of China Resources Medical Holdings Company Limited from February 27, 2023. He is the general manager of China Resources Health Group Limited, and...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Baojie Shan
VP & Executive Director2.9yrsCN¥3.24msin datos
Qing Song
Executive Chairman of the Board6.3yrsCN¥71.00k0.031%
HK$ 1.5m
Hai Yu
CEO & Executive Director1.8yrssin datossin datos
Min Yang
CFO & Executive Director1.4yrssin datossin datos
Ming Fai Chung
Company Secretaryless than a yearsin datossin datos

1.8yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 1515 no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Baojie Shan
VP & Executive Director3.3yrsCN¥3.24msin datos
Qing Song
Executive Chairman of the Board6.3yrsCN¥71.00k0.031%
HK$ 1.5m
Hai Yu
CEO & Executive Director1.8yrssin datossin datos
Min Yang
CFO & Executive Director1.4yrssin datossin datos
Yuning Fu
Honorary Chairman8yrssin datossin datos
Tingmei Fu
Independent Non-Executive Director1.8yrssin datossin datos
Ting Yuk Wu
Independent Non-Executive Director6.3yrsCN¥257.00ksin datos
Kwok Kong Kwong
Independent Non-Executive Director11.2yrsCN¥257.00ksin datos
Lu Ge
Non-Executive Director1.2yrssin datos0.0051%
HK$ 245.5k
Peng Zhou
Independent Non-Executive Director1.2yrsCN¥81.00ksin datos

2.5yrs

Permanencia media

57yo

Promedio de edad

Junta con experiencia: La junta directiva de 1515 no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.